What labs should be monitored in a patient with a snake bite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Monitoring in Snake Envenomation

In snake envenomation cases, comprehensive laboratory monitoring should include complete blood count, coagulation studies (PT/INR, aPTT, fibrinogen), renal function tests, and electrolytes to assess for hemolysis, coagulopathy, and organ dysfunction. 1

Initial Laboratory Assessment

  • Complete Blood Count (CBC):

    • Hemoglobin/hematocrit: To assess for anemia from hemolysis
    • Platelet count: To monitor for thrombocytopenia
    • White blood cell count: To evaluate inflammatory response
  • Coagulation Studies:

    • Prothrombin Time (PT)/International Normalized Ratio (INR)
    • Activated Partial Thromboplastin Time (aPTT)
    • Fibrinogen levels: Often markedly decreased in envenomation
    • 20-minute Whole Blood Clotting Test (20WBCT): Bedside test recommended by WHO for diagnosis of significant coagulopathy 2
  • Chemistry Panel:

    • Electrolytes
    • Blood Urea Nitrogen (BUN) and Creatinine: To assess renal function
    • Liver function tests (AST, ALT)
    • Creatine kinase: To evaluate for rhabdomyolysis

Timing and Frequency of Monitoring

  1. Initial labs: Immediately upon arrival at emergency department
  2. Follow-up labs: Every 6 hours for the first 24 hours 3
  3. Extended monitoring: Continue monitoring until laboratory values normalize

Specific Tests Based on Clinical Presentation

For Coagulopathy Assessment

  • Fibrin degradation products (FDPs): May peak at extremely high levels (mean of 7,680 μg/ml reported in Eastern diamondback rattlesnake bites) 3
  • D-dimer: To assess for fibrinolysis
  • Thrombin time: Values ≥120 seconds indicate incoagulable blood 3

For Hemolysis Evaluation

  • Peripheral blood smear: To look for schistocytes (>1.0% indicates thrombotic microangiopathy) 4
  • Lactate dehydrogenase (LDH)
  • Haptoglobin
  • Free hemoglobin

For Renal Function Assessment

  • Urinalysis: To check for hematuria, myoglobinuria
  • Serum creatinine and BUN: Serial measurements to monitor for acute kidney injury

Diagnostic Accuracy of Coagulation Tests

  • INR >1.155 has a sensitivity of 78.5% and specificity of 90.3% for detecting hypofibrinogenemia 2
  • 20WBCT has sensitivity of 81.0% and specificity of 90.3% for detecting hypofibrinogenemia 2
  • Both 20WBCT and INR are superior to aPTT for assessing coagulation abnormalities in viper bites 2, 5

Monitoring for Specific Complications

Thrombotic Microangiopathy

  • Diagnostic criteria: Anemia with >1.0% schistocytes on blood film, plus thrombocytopenia (<150 × 10⁹/L) or relative decrease in platelet count >25% from baseline 4
  • Monitor for acute kidney injury which may require dialysis

Venom-Induced Consumption Coagulopathy

  • Characterized by prolonged PT/INR, decreased fibrinogen
  • May not show classic DIC pattern (platelet counts and antithrombin III levels may remain relatively normal) 3

Common Pitfalls and Considerations

  1. Anticoagulant Interference: Heparin in samples may affect coagulation tests; use heparin neutralizers when appropriate 6

  2. Timing Considerations: The magnitude and duration of coagulopathy are proportional to the clinical severity of envenomation 3

  3. Antivenom Effect: Treatment with antivenom can blunt the coagulopathy, which should be considered when interpreting laboratory results 3

  4. Long-term Monitoring: Patients are at risk for chronic kidney disease following thrombotic microangiopathy, requiring long-term follow-up 4

By systematically monitoring these laboratory parameters, clinicians can effectively assess the severity of envenomation, guide antivenom administration, and detect complications early to improve patient outcomes.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.